# Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

> **NCT04879563** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Region Örebro County** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer
- Prostate Cancer
- Quality of Life
- Survivorship
- Toxicity

## Interventions

- **OTHER:** ASCAPE-based follow-up strategy

## Key facts

- **NCT ID:** NCT04879563
- **Lead sponsor:** Region Örebro County
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04879563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04879563, "Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04879563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*